Skip to content

Nichols Advantage Chemiluminescence Thyroid Stimulating Hormone Third Generation Kit

by Nichols Institute Diagnostics 510(k)

Active United States

510(k) K961650

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK961650 Date16 Jul 1996ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
JLW
Device Class
Class II
Regulation
21 CFR Part 862.1690
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 6 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Nichols Advantage Chemiluminescence Thyroid Stimulating Hormone Third Generation Kit is a radioimmunoassay device used for the measurement of thyroid-stimulating hormone. It is classified as a device in the clinical chemistry medical specialty.

The device is supplied as a kit and is intended for use in a clinical setting. It has been assigned a regulation number of 862.1690 and has been cleared by the FDA with a K number of K961650. The device is classified as a class 2 device with a traditional clearance type.

Other devices from Quest Diagnostics Nichols Institute

See all devices from Quest Diagnostics Nichols Institute →